← Open Payments lookup

MARISSA MORITZ-GUZIK: Open Payments

NPI 1457669772 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$66,920 in 230 payments from 16 companies in 2025. Trend: 2023 $2,627 · 2024 $21,141 · 2025 $66,920

Speaker / faculty: $48,182Travel & lodging: $11,746Food & beverage: $4,442Consulting: $2,550
CompanyPaymentsAmount
Janssen Biotech, Inc.47$38,095
Lilly USA, LLC58$25,967
ABBVIE INC.37$679
Madrigal Pharmaceuticals9$536
GENZYME CORPORATION11$364
Salix Pharmaceuticals, a division of Bausch Health US, LLC16$309
Takeda Pharmaceuticals U.S.A., Inc.16$239
Phathom Pharmaceuticals, Inc.12$235
Gilead Sciences, Inc.7$154
Aimmune Therapeutics, Inc.4$76

Products named: TREMFYA, OMVOH, STELARA, REZDIFFRA, DUPIXENT, XIFAXAN, VOQUEZNA, SKYRIZI.

Industry payments across CO — which companies pay providers there.